Biotech

Startups News

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 12.07.2022.

Venture capital
Biotechnology
Pharmaceutical drug
Medicine
Alfred P. Sloan
Ideal gas law

@John_LaMattina shared
On Jul 6, 2022
RT @LifeSciVC: Surprising Resilience Of Private VC-Backed Biotech Markets 2022 is off to fastest start for VC financings than every year except '21 Over $6B has been invested in 2Q 2022 far more than 2Q in all but 2020-'21 June 2022 was also huge, 2nd biggest ever https://t.co/jxSSGnU2rk
Open
Surprising Resilience Of Private VC-Backed Biotech Markets

Surprising Resilience Of Private VC-Backed Biotech Markets

It’s biotech armageddon out there: with massive value destruction across public stocks, it’s clearly the worst market backdrop in over 20 years. Nothing like this pullback has happened in ...

@matthewherper shared
On Jul 8, 2022
RT @adamfeuerstein: This week's Readout LOUD -- @ADeAngelis_bio joins us to talk DOOM times for bio VCs (okay, not exactly but I like riling @LifeSciVC) -- Also, @damiangarde and I Chat Cathys about $AMLX $ICPT $BIIB $ESALY Listen to very end for a @megtirrell Easter egg!https://t.co/ZH3LH6F8KF
Open
Listen: VC malaise, FDA confusion, & yet another Alzheimer’s debate

Listen: VC malaise, FDA confusion, & yet another Alzheimer’s debate

Is the era of the unicorn over? What's gotten into the FDA? And will a NASH drug ever work? Find out on the latest episode of "The Readout LOUD" #podcast. Listen now:

@BentheFidler shared
On Jul 8, 2022
After a lengthy drought, could #biotech M&A be on the upswing? A look at the latest numbers by @realJacobBell https://t.co/QNIqm0mare $MRK $SGEN $BHVN $PFE
Open
After a lengthy drought, could biotech M&A be on the upswing?

After a lengthy drought, could biotech M&A be on the upswing?

With at least 14 buyouts worth $50 million or more, the second quarter was one of the busiest three-month periods for acquisitions in recent years. Some industry watchers expect that pace ...

@BentheFidler shared
On Jul 11, 2022
Healthcare asset manager Innoviva buys another biotech at a bargain price https://t.co/ktylCXaKU1 @ByJonGardner $INVA $LJPC $ETTX
Open
Healthcare asset manager Innoviva buys another biotech at a bargain price

Healthcare asset manager Innoviva buys another biotech at a bargain price

Two months after acquiring Entasis Therapeutics, the firm reached a deal to buy La Jolla Pharmaceutical Co. at a fraction of what La Jolla was worth just a few years ago.

@IAmBiotech shared
On Jul 11, 2022
Recess is over, and USDA is calling for increased investment in food and ag innovation by G20 members. Plus, a https://t.co/9hOxRo6BPd exclusive opinion piece from BAKX Therapeutics’ CEO, who makes a case for “founder-centric biotech.” https://t.co/o6YuCTYBCo
Open
Good Day BIO: USDA calls for ‘ambitious investment’ in innovation

Good Day BIO: USDA calls for ‘ambitious investment’ in innovation

Recess is over, and USDA is calling for increased investment in food and ag innovation by G20 members. Plus, a Bio.News exclusive opinion piece from BAKX Therapeutics’ CEO, who makes a case ...

@big4bio shared
On Jul 6, 2022
RT @biostartupnews: Here's the latest edition of BioStartup News! Catch the most recent updates going on with #lifescience #startups across the US! https://t.co/B2073VAZQx July 6: Vivera Appoints Exec; ReCode Raises $120M; Anebulo's Phase 2 Data #Biotech #Funding https://t.co/gf7VWUcoSr
Open
July 6, 2022

July 6, 2022

Anebulo Pharmaceuticals: Positive Topline Data for ANEB-001 From a Phase 2 Clinical Trial for Acute Cannabinoid Intoxication More More More* BioXcel Therapeutics: Appoints Michael …

@MassBio shared
On Jul 7, 2022
Lab is on the move? It’s important to work closely with your gas supplier to address the gas-related issues that arise during pre-move site visits and throughout the transition to your new facility. Read how @MiddlesexGases can help ease your relocation. https://t.co/m0XkTGUfiY https://t.co/WqmwQsYquD
Open
Is your lab on the move? Getting your gas supplier involved from the beginning can save dollars and headaches.

Is your lab on the move? Getting your gas supplier involved from the beginning can save dollars and headaches.

Cambridge, Massachusetts is the region’s mecca for start-ups and well-established organizations in the life sciences, biotech, pharma, and health-care industries. With so many of these ...

@BusinessInsider shared
On Jul 11, 2022
Here's the salary breakdown for MIT's MBA class of 2021 across industries https://t.co/wOybcDmJrf
Open
Here's the salary breakdown for MIT's MBA class of 2021 across industries

Here's the salary breakdown for MIT's MBA class of 2021 across industries

The median salary for 2021 Sloan graduates was $150,000, with a median signing bonus of $30,000, according to Sloan's 2021-2022 employment report.

Read more:
weekly 12.07.2022
View archives
Back to home

Subscribe to Biotech - Startups.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Startups.
Privacy Policy

Sign up for the weekly Biotech - Startups newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Startups weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy